PD-1/PD-L pathway inhibits M.tb-specific CD4+ T-cell functions and phagocytosis of macrophages in active tuberculosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PD-1/PD-L pathway inhibits M.tb-specific CD4+ T-cell functions and phagocytosis of macrophages in active tuberculosis
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-12-07
DOI
10.1038/srep38362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses
- (2015) Yan Gao et al. HUMAN IMMUNOLOGY
- Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients
- (2015) Isabel Sada-Ovalle et al. Journal of the International AIDS Society
- The WHO 2014 Global tuberculosis report—further to go
- (2015) Alimuddin Zumla et al. Lancet Global Health
- PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment
- (2015) Syeda S. Hassan et al. PLoS One
- Programmed Death (PD)-1:PD-Ligand 1/PD-Ligand 2 Pathway Inhibits T Cell Effector Functions during Human Tuberculosis
- (2014) J. O. Jurado et al. JOURNAL OF IMMUNOLOGY
- Inhibiting the Programmed Death 1 Pathway Rescues Mycobacterium tuberculosis–Specific Interferon γ–Producing T Cells From Apoptosis in Patients With Pulmonary Tuberculosis
- (2013) Amar Singh et al. JOURNAL OF INFECTIOUS DISEASES
- PD-1/PD-Ls pathways between CD4+ T cells and pleural mesothelial cells in human tuberculous pleurisy
- (2013) Wen Yin et al. TUBERCULOSIS
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of the PD-1 pathway in autoimmunity and peripheral tolerance
- (2011) Brian T. Fife et al. Annals of the New York Academy of Sciences
- T Cells from Programmed Death-1 Deficient Mice Respond Poorly to Mycobacterium tuberculosis Infection
- (2011) Sultan Tousif et al. PLoS One
- The PD-1 pathway in tolerance and autoimmunity
- (2010) Loise M. Francisco et al. IMMUNOLOGICAL REVIEWS
- PD-1-PD-L1 pathway impairs Th1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guerin
- (2010) S. Sakai et al. INTERNATIONAL IMMUNOLOGY
- CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition
- (2010) D. L. Barber et al. JOURNAL OF IMMUNOLOGY
- Role Played by the Programmed Death‐1–Programmed Death Ligand Pathway during Innate Immunity againstMycobacterium tuberculosis
- (2010) Ivana B. Alvarez et al. JOURNAL OF INFECTIOUS DISEASES
- Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis
- (2010) E. Lazar-Molnar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PD-L2 induction on dendritic cells exposed to Mycobacterium avium downregulates BCG-specific T cell response
- (2010) Elizabeth Mendoza-Coronel et al. TUBERCULOSIS
- Enhancing therapeutic vaccination by blocking PD-1–mediated inhibitory signals during chronic infection
- (2008) Sang-Jun Ha et al. JOURNAL OF EXPERIMENTAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now